Search Results - "ELEFTHERIADIS, Haralabos"
-
1
Ranibizumab Plus Panretinal Photocoagulation versus Panretinal Photocoagulation Alone for High-Risk Proliferative Diabetic Retinopathy (PROTEUS Study)
Published in Ophthalmology (Rochester, Minn.) (01-05-2018)“…Comparison of the efficacy of ranibizumab (RBZ) 0.5 mg intravitreal injections plus panretinal photocoagulation (PRP) versus PRP alone in the regression of the…”
Get full text
Journal Article -
2
Randomised trial of wide-field guided PRP for diabetic macular oedema treated with ranibizumab
Published in Eye (London) (01-06-2019)“…Background Diabetic macular oedema (DMO) is effectively treated with ranibizumab but multiple injections are required. Where there is also peripheral…”
Get full text
Journal Article -
3
Aflibercept in clinical practice; visual acuity, injection numbers and adherence to treatment, for diabetic macular oedema in 21 UK hospitals over 3 years
Published in Eye (London) (01-01-2022)“…Introduction Randomised controlled trials provide evidence that a treatment works. Real world evidence is required to assess if proven treatments are effective…”
Get full text
Journal Article -
4
Standard threshold laser versus subthreshold micropulse laser for adults with diabetic macular oedema: the DIAMONDS non-inferiority RCT
Published in Health technology assessment (Winchester, England) (01-12-2022)“…The National Institute for Health and Care Excellence recommends macular laser to treat diabetic macular oedema with a central retinal subfield thickness of <…”
Get full text
Journal Article -
5
Estimating excess visual loss from neovascular age-related macular degeneration in the UK during the COVID-19 pandemic: a retrospective clinical audit and simulation model
Published in BMJ open (15-04-2022)“…ObjectivesTo report the reduction in new neovascular age-related macular degeneration (nAMD) referrals during the COVID-19 pandemic and estimate the impact of…”
Get full text
Journal Article -
6
Diabetic macular oedema and diode subthreshold micropulse laser (DIAMONDS): study protocol for a randomised controlled trial
Published in Current controlled trials in cardiovascular medicine (12-02-2019)“…In the UK, macular laser is the treatment of choice for people with diabetic macular oedema with central retinal subfield thickness (CST) < 400 μm, as per…”
Get full text
Journal Article -
7
Eplerenone for chronic central serous chorioretinopathy in patients with active, previously untreated disease for more than 4 months (VICI): a randomised, double-blind, placebo-controlled trial
Published in The Lancet (British edition) (25-01-2020)“…In chronic central serous chorioretinopathy (CSCR), fluid accumulates in the subretinal space. CSCR is a common visually disabling condition that develops in…”
Get full text
Journal Article -
8
Comments to: Accuracy of biometric formulae in hypermetropic patients undergoing cataract surgery
Published in European journal of ophthalmology (01-01-2022)Get full text
Journal Article -
9
Comments to: Valsalva retinopathy associated with intranasal cocaine abuse: A case report
Published in European journal of ophthalmology (01-01-2022)Get full text
Journal Article -
10
Diabetic Macular Edema and Diode Subthreshold Micropulse Laser: A Randomized Double-Masked Noninferiority Clinical Trial
Published in Ophthalmology (Rochester, Minn.) (01-01-2023)“…To determine clinical effectiveness, safety, and cost-effectiveness of subthreshold micropulse laser (SML), compared with standard laser (SL), for diabetic…”
Get full text
Journal Article -
11
Multimodal Imaging in a Case of Peripapillary Choroidal Neovascular Membrane Associated With Idiopathic Intracranial Hypertension
Published in Journal of neuro-ophthalmology (01-03-2021)“…Optical coherence tomography angiography is one of the latest noninvasive imaging modalities for visualizing the vasculature of retina and choroid. We describe…”
Get full text
Journal Article -
12
Diabetic Macular Edema and Diode Subthreshold Micropulse Laser
Published in Ophthalmology (Rochester, Minn.) (01-01-2023)“…To determine clinical effectiveness, safety, and cost-effectiveness of subthreshold micropulse laser (SML), compared with standard laser (SL), for diabetic…”
Get full text
Journal Article -
13
Model for Risk-Based Screening of Diabetic Retinopathy in People With Newly-Diagnosed Type 2 Diabetes Mellitus
Published in Investigative ophthalmology & visual science (01-05-2017)“…The purpose of this study was to evaluate the role of inflammatory/lipid markers and potential risk factors for diabetic retinopathy (DR) development in newly…”
Get full text
Journal Article -
14
Evaluation of a New Model of Care for People with Complications of Diabetic Retinopathy: The EMERALD Study
Published in Ophthalmology (Rochester, Minn.) (01-04-2021)“…The increasing diabetes prevalence and advent of new treatments for its major visual-threatening complications (diabetic macular edema [DME] and proliferative…”
Get full text
Journal Article -
15
Real world evidence on 5661 patients treated for macular oedema secondary to branch retinal vein occlusion with intravitreal anti-vascular endothelial growth factor, intravitreal dexamethasone or macular laser
Published in British journal of ophthalmology (01-04-2021)“…Clinical trials suggest anti-vascular endothelial growth factor is more effective than intravitreal dexamethasone as treatment for macular oedema secondary to…”
Get more information
Journal Article -
16
United Kingdom Diabetic Retinopathy Electronic Medical Record (UK DR EMR) Users Group: report 4, real-world data on the impact of deprivation on the presentation of diabetic eye disease at hospital services
Published in British journal of ophthalmology (01-06-2019)“…To assess the impact of deprivation on diabetic retinopathy presentation and related treatment interventions, as observed within the UK hospital eye service…”
Get more information
Journal Article -
17
-
18
Patients views on a new surveillance pathway involving allied non-medical staff for people with treated diabetic macular oedema and proliferative diabetic retinopathy
Published in Eye (London) (01-04-2023)“…Background/Objective To explore acceptability by patients and health care professionals of a new surveillance pathway for people with previously treated and…”
Get full text
Journal Article -
19
Subthreshold micropulse laser versus standard laser for the treatment of central-involving diabetic macular oedema with central retinal thickness of <400µ: a cost-effectiveness analysis from the DIAMONDS trial
Published in BMJ open (18-10-2023)“…ObjectivesTo estimate the economic costs, health-related quality-of-life outcomes and cost-effectiveness of subthreshold micropulse laser (SML) versus standard…”
Get full text
Journal Article -
20
Evaluation of a New Model of Care for People with Complications of Diabetic Retinopathy
Published in Ophthalmology (Rochester, Minn.) (01-04-2021)“…The increasing diabetes prevalence and advent of new treatments for its major visual-threatening complications (diabetic macular edema [DME] and proliferative…”
Get full text
Journal Article